-transparent.png){kind=logo}
Gaschromatography--mass spectrometry (GC/MS) was used to determine plasma levels of oxcarbazepine (OCB) and its main metabolite in a newborn girl and her OCB-treated mother during the first five post partum days. At delivery the maternal and neonatal plasma concentrations were in the same range, indicating considerable placental transfer of both substances. In spite of ingestion of both substances via breast milk, there was no accumulation in the baby. On the fifth post partum day OCB and 10-hydroxy-carbazepine (10-OH-CB) levels in plasma in the newborn were only 12 and 7%, respectively, of the values found on the first day after delivery.
Related Publications
P Bülau, and
W D Paar, and
G E von Unruh
October 1993,
British journal of clinical pharmacology,
P Bülau, and
W D Paar, and
G E von Unruh
December 1986,
Biomedical & environmental mass spectrometry,
P Bülau, and
W D Paar, and
G E von Unruh
September 1983,
Acta neurologica Scandinavica,
P Bülau, and
W D Paar, and
G E von Unruh
January 1997,
Biopharmaceutics & drug disposition,
P Bülau, and
W D Paar, and
G E von Unruh
February 2003,
Therapeutic drug monitoring,
P Bülau, and
W D Paar, and
G E von Unruh
June 1996,
Acta neurologica Scandinavica,
P Bülau, and
W D Paar, and
G E von Unruh
September 2015,
Seizure,
P Bülau, and
W D Paar, and
G E von Unruh
January 1989,
European journal of clinical pharmacology,
P Bülau, and
W D Paar, and
G E von Unruh
May 2006,
Epilepsy research,
P Bülau, and
W D Paar, and
G E von Unruh
February 2016,
European journal of clinical pharmacology,
